Clinical trial
Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders
NCT00417066 · Eugonia, Other · Completed
Key facts
| NCT number | NCT00417066 |
|---|---|
| Title | Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders |
| Official title | The Flexible GnRH Antagonist Protocol Provides Better Results (IVF Outcomes) Than Flare up GnRH Agonist Protocol in Poor Responders |
| Lead sponsor | Eugonia, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Infertility, Premature Ovarian Failure |
| Intervention type | Drug |
| Interventions | Ganirelix 0.25mg (Orgalutran, Organon, The Netherlands), Arvekap 0.1mg (Triptorelin, Ipsen, France) |
| Enrollment | 270 |
| Start date | Sep 1, 2003 |
| Completion | Jul 1, 2006 |
| First posted | Dec 29, 2006 |
| Last update posted | Dec 16, 2013 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: